Experimental models, such as those using type II collagen to induce arthritis, have shown that the activation of α7 nicotinic acetylcholine receptors (α7nAChRs), for instance, through nicotine, can significantly reduce synovial TNF-α levels, mitigate joint inflammation, and limit histopathological damage. The gene discussed is CHRNA7; the disease is arthritic joint disease.